Shares of Clarus Corporation (NASDAQ:CLAR – Get Free Report) have received a consensus rating of “Hold” from the five ratings firms that are currently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating on the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $3.6333.
A number of research firms have recently weighed in on CLAR. Lake Street Capital lowered their price objective on Clarus from $3.50 to $3.00 and set a “hold” rating on the stock in a research report on Friday, March 6th. Roth Mkm set a $2.90 price objective on Clarus in a research report on Wednesday, May 13th. Zacks Research downgraded Clarus from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, May 27th. Wall Street Zen raised Clarus from a “sell” rating to a “hold” rating in a research note on Saturday, April 11th. Finally, Stifel Nicolaus set a $5.00 target price on Clarus in a research note on Thursday, April 16th.
Read Our Latest Report on Clarus
Clarus Stock Down 0.3%
Clarus (NASDAQ:CLAR – Get Free Report) last posted its quarterly earnings data on Thursday, March 5th. The company reported $0.09 earnings per share for the quarter, beating analysts’ consensus estimates of $0.06 by $0.03. Clarus had a negative return on equity of 0.11% and a negative net margin of 17.70%.The firm had revenue of $65.41 million for the quarter, compared to analysts’ expectations of $68.67 million.
Clarus Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 27th. Investors of record on Monday, May 18th were paid a dividend of $0.025 per share. This represents a $0.10 annualized dividend and a yield of 3.5%. The ex-dividend date of this dividend was Monday, May 18th. Clarus’s dividend payout ratio (DPR) is -8.62%.
Institutional Trading of Clarus
Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Russell Investments Group Ltd. raised its stake in Clarus by 4.4% during the 3rd quarter. Russell Investments Group Ltd. now owns 1,398,258 shares of the company’s stock valued at $4,894,000 after purchasing an additional 58,821 shares during the period. Parthenon LLC raised its stake in Clarus by 39.6% during the 4th quarter. Parthenon LLC now owns 1,005,364 shares of the company’s stock valued at $3,368,000 after purchasing an additional 285,124 shares during the period. Potomac Capital Management Inc. bought a new stake in Clarus during the 4th quarter valued at approximately $3,244,000. Geode Capital Management LLC raised its stake in Clarus by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 702,446 shares of the company’s stock valued at $2,354,000 after purchasing an additional 3,611 shares during the period. Finally, Peapod Lane Capital LLC raised its stake in Clarus by 9.3% during the 3rd quarter. Peapod Lane Capital LLC now owns 530,183 shares of the company’s stock valued at $1,855,000 after purchasing an additional 44,963 shares during the period. Institutional investors own 90.30% of the company’s stock.
About Clarus
Clarus Corporation (NASDAQ: CLAR) is a global designer, manufacturer and marketer of outdoor recreation equipment. The company’s portfolio of brands serves enthusiasts across climbing, skiing, trail running, paddling and snow safety, combining purpose-driven innovation with in-house manufacturing capabilities. Clarus focuses on high-performance gear developed to meet the demands of professional athletes and recreational users alike.
The company’s flagship brand, Black Diamond Equipment, offers climbing protection, apparel, ski bindings and accessories engineered for backcountry and alpine environments.
Read More
- Five stocks we like better than Clarus
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Receive News & Ratings for Clarus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarus and related companies with MarketBeat.com's FREE daily email newsletter.
